✦ LIBER ✦

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

✍ Scribed by Grothey, Axel; Cutsem, Eric Van; Sobrero, Alberto; Siena, Salvatore; Falcone, Alfredo; Ychou, Marc; Humblet, Yves; Bouché, Olivier; Mineur, Laurent; Barone, Carlo; Adenis, Antoine; Tabernero, Josep; Yoshino, Takayuki; Lenz, Heinz-Josef; Goldberg, Richard M; Sargent, Daniel J; Cihon, Frank; Cupit, Lisa; Wagner, Andrea; Laurent, Dirk

Book ID: 121327395
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 324 KB
Volume: 381
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(12)61900-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ramucirumab monotherapy for previously t

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

✍ Fuchs, Charles S; Tomasek, Jiri; Yong, Cho Jae; Dumitru, Filip; Passalacqua, Rod 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 690 KB

TAS-102 monotherapy for pretreated metas

TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial

✍ Takayuki Yoshino; Nobuyuki Mizunuma; Kentaro Yamazaki; Tomohiro Nishina; Yoshito 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 286 KB

Efficacy and safety of regorafenib for a

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

✍ Demetri, George D; Reichardt, Peter; Kang, Yoon-Koo; Blay, Jean-Yves; Rutkowski, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 348 KB